ConductScience.org, home

Paper33713223

Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications.

Terekhov RP and 9 others. Bull Exp Biol Med, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications. Papers, record 33713223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33713223

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic Modifications.
PubMed
Journal
Bull Exp Biol Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2022-02-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Terekhov RPR P
2Selivanova IAI A
3Anurova MNM N
4Zhevlakova AKA K
5Nikitin IDI D
6Cong ZZh
7Ma SS
8Yang FF
9Dong ZZ
10Liao YY

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuercetinMajor topic
Wound HealingMajor topic
Animals
Male
Polymorphism, Genetic
Rats
Rats, Sprague-Dawley
Regenerative Medicine

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130950819[Analysis of dihydroquercetin physical modification via in vitro and in silico methods].Biomed Khim2019https://conductscience.org/library/papers/30950819PubMed
224694757Comparison of efficacy of topical phenytoin with hypericin in second-degree burn wound healing: an experimental study in rats.Med Sci Monit Basic Res2014https://conductscience.org/library/papers/24694757PubMed
325850419Toxicological and Genotoxicity Assessment of a Dihydroquercetin-Rich Dahurian Larch Tree (Larix gmelinii Rupr) Extract (Lavitol).Int J Toxicol2015https://conductscience.org/library/papers/25850419PubMed
419426789Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior.Int J Pharm2009https://conductscience.org/library/papers/19426789PubMed
527649117Detection of 191 Taxifolin Metabolites and Their Distribution in Rats Using HPLC-ESI-IT-TOF-MS(n).Molecules2016https://conductscience.org/library/papers/27649117PubMed
632455534Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.Int J Mol Sci2020https://conductscience.org/library/papers/32455534PubMed
731081996Hyaluronic acid hydrogel loaded by adipose stem cells enhances wound healing by modulating IL-1β, TGF-β1, and bFGF in burn wound model in rat.J Biomed Mater Res B Appl Biomater2020https://conductscience.org/library/papers/31081996PubMed
831338467Cell cytotoxity and anti-glycation activity of taxifolin-rich extract from Japanese larch, Larix kaempferi.Heliyon2019https://conductscience.org/library/papers/31338467PubMed
928577102Dihydroquercetin Improves Microvascularization and Microcirculation in the Brain Cortex of SHR Rats during the Development of Arterial Hypertension.Bull Exp Biol Med2017https://conductscience.org/library/papers/28577102PubMed
1017672120[Methods of determination of sizes of the wound surface].Vestn Khir Im I I Grek2007https://conductscience.org/library/papers/17672120PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41958938Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review.Front Pharmacol2026https://conductscience.org/library/papers/41958938PubMed
41304920Dihydroquercetin in Weight Control: Systematic Review and Meta-Analysis of Preclinical Studies.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304920PubMed
40144465Insights in wound healing properties of water-soluble composition of dihydroquercetin and L-lysine.J Pharm Pharm Sci2025https://conductscience.org/library/papers/40144465PubMed
37836832Research Progress of Dihydroquercetin in the Treatment of Skin Diseases.Molecules2023https://conductscience.org/library/papers/37836832PubMed
37569337Protective Properties of Spheroidal Taxifolin Form in Streptozotocin-Induced Diabetic Rats.Int J Mol Sci2023https://conductscience.org/library/papers/37569337PubMed
36837879LC-MS/MS and GC/MS Profiling of Petroselinum sativum Hoffm. and Its Topical Application on Burn Wound Healing and Related Analgesic Potential in Rats.Metabolites2023https://conductscience.org/library/papers/36837879PubMed
36555607Solubility Enhancement of Dihydroquercetin via "Green" Phase Modification.Int J Mol Sci2022https://conductscience.org/library/papers/36555607PubMed
35682702Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling.Int J Mol Sci2022https://conductscience.org/library/papers/35682702PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33713223

GET https://conductscience.org/api/papers/v1/33713223/authors